Fibrocell Science to Present at Barclays Global Healthcare Conference 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science (NYSEMKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for skin diseases and conditions with high unmet medical needs, today announced that David Pernock, chairman and chief executive officer of Fibrocell Science, will present at the Barclays Global Healthcare Conference 2014 at 2:30 pm EDT on Wednesday, March 12, 2014, at the Loews Hotel in Miami. Mr. Pernock will discuss the company’s autologous fibroblast technology, its therapeutic candidates in development, and its collaboration with Intrexon Corporation (NYSE:XON) to develop genetically-modified personalized biologics.